GenRx Voriconazole voriconazole 200mg tablet blister pack

Active ingredient:

voriconazole, Quantity: 200 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Voriconazole

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: magnesium stearate; polyvinyl alcohol; croscarmellose sodium; macrogol 8000; purified talc; titanium dioxide; lactose monohydrate

Administration route:

Oral

Units in package:

56

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Voriconazole is indicated for treatment of the following fungal infections: ? Invasive aspergillosis. ? Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). ? Serious fungal infections caused by Scedosporium spp and Fusarium spp. ? Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Product summary:

Visual Identification: White coloured, modified oval-shaped, biconvex film-coated tablets, engraved with "APO" on one side and "VOR 200" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-01-27